Logo image of OM

OUTSET MEDICAL INC (OM) Stock Fundamental Analysis

NASDAQ:OM - Nasdaq - US6901452069 - Common Stock - Currency: USD

17.57  -0.04 (-0.23%)

After market: 17.57 0 (0%)

Fundamental Rating

2

OM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of OM have multiple concerns. OM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OM had negative earnings in the past year.
In the past year OM has reported a negative cash flow from operations.
OM had negative earnings in each of the past 5 years.
OM had a negative operating cash flow in each of the past 5 years.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

OM has a worse Return On Assets (-37.79%) than 61.17% of its industry peers.
The Return On Equity of OM (-67.00%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -37.79%
ROE -67%
ROIC N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

OM has a Gross Margin of 35.93%. This is in the lower half of the industry: OM underperforms 69.68% of its industry peers.
OM's Gross Margin has improved in the last couple of years.
OM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OM has been increased compared to 1 year ago.
The number of shares outstanding for OM has been increased compared to 5 years ago.
OM has a worse debt/assets ratio than last year.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OM has an Altman-Z score of -3.39. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
OM's Altman-Z score of -3.39 is on the low side compared to the rest of the industry. OM is outperformed by 67.02% of its industry peers.
OM has a Debt/Equity ratio of 0.55. This is a neutral value indicating OM is somewhat dependend on debt financing.
The Debt to Equity ratio of OM (0.55) is worse than 64.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -3.39
ROIC/WACCN/A
WACC7.29%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

OM has a Current Ratio of 8.37. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.37, OM belongs to the best of the industry, outperforming 88.83% of the companies in the same industry.
OM has a Quick Ratio of 6.74. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
OM has a better Quick ratio (6.74) than 87.23% of its industry peers.
Industry RankSector Rank
Current Ratio 8.37
Quick Ratio 6.74
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.80% over the past year.
Looking at the last year, OM shows a decrease in Revenue. The Revenue has decreased by -7.84% in the last year.
The Revenue has been growing by 49.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)47.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.11%
Revenue 1Y (TTM)-7.84%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%5.62%

3.2 Future

The Earnings Per Share is expected to grow by 14.87% on average over the next years. This is quite good.
Based on estimates for the next years, OM will show a quite strong growth in Revenue. The Revenue will grow by 13.23% on average per year.
EPS Next Y83.41%
EPS Next 2Y36.17%
EPS Next 3Y22.99%
EPS Next 5Y14.87%
Revenue Next Year8.54%
Revenue Next 2Y10.25%
Revenue Next 3Y10.58%
Revenue Next 5Y13.23%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 -20 -40 -60 -80

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OM. In the last year negative earnings were reported.
Also next year OM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

OM's earnings are expected to grow with 22.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.17%
EPS Next 3Y22.99%

More info and screens

0

5. Dividend

5.1 Amount

OM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTSET MEDICAL INC

NASDAQ:OM (5/30/2025, 8:24:20 PM)

After market: 17.57 0 (0%)

17.57

-0.04 (-0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners46.67%
Inst Owner Change-29.69%
Ins Owners2.13%
Ins Owner Change42.72%
Market Cap311.34M
Analysts83.08
Price Target22.19 (26.29%)
Short Float %6.42%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-109.98%
Min EPS beat(2)-232.87%
Max EPS beat(2)12.92%
EPS beat(4)2
Avg EPS beat(4)-52.69%
Min EPS beat(4)-232.87%
Max EPS beat(4)12.92%
EPS beat(8)3
Avg EPS beat(8)-27.85%
EPS beat(12)4
Avg EPS beat(12)-22.29%
EPS beat(16)6
Avg EPS beat(16)-16.31%
Revenue beat(2)2
Avg Revenue beat(2)2.17%
Min Revenue beat(2)0.47%
Max Revenue beat(2)3.86%
Revenue beat(4)3
Avg Revenue beat(4)-1.74%
Min Revenue beat(4)-14.74%
Max Revenue beat(4)3.86%
Revenue beat(8)4
Avg Revenue beat(8)-2.73%
Revenue beat(12)7
Avg Revenue beat(12)-1.97%
Revenue beat(16)10
Avg Revenue beat(16)-1.05%
PT rev (1m)0%
PT rev (3m)480%
EPS NQ rev (1m)-34.24%
EPS NQ rev (3m)-594.58%
EPS NY rev (1m)-31.12%
EPS NY rev (3m)-402.89%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)-1.76%
Revenue NY rev (1m)1.67%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 1.83
P/tB 1.83
EV/EBITDA N/A
EPS(TTM)-21.69
EYN/A
EPS(NY)-3.93
Fwd EYN/A
FCF(TTM)-5.46
FCFYN/A
OCF(TTM)-5.42
OCFYN/A
SpS6.51
BVpS9.59
TBVpS9.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.79%
ROE -67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.93%
FCFM N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.24%
Cap/Sales 0.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.37
Quick Ratio 6.74
Altman-Z -3.39
F-Score6
WACC7.29%
ROIC/WACCN/A
Cap/Depr(3y)78.75%
Cap/Depr(5y)116.96%
Cap/Sales(3y)3.55%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.11%
EPS Next Y83.41%
EPS Next 2Y36.17%
EPS Next 3Y22.99%
EPS Next 5Y14.87%
Revenue 1Y (TTM)-7.84%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%5.62%
Revenue Next Year8.54%
Revenue Next 2Y10.25%
Revenue Next 3Y10.58%
Revenue Next 5Y13.23%
EBIT growth 1Y43.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.7%
EBIT Next 3Y17.24%
EBIT Next 5Y15.99%
FCF growth 1Y39.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.87%
OCF growth 3YN/A
OCF growth 5YN/A